These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 11024374

  • 1. Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping.
    Sunderdiek U, Feindt P, Gams E.
    Eur J Cardiothorac Surg; 2000 Oct; 18(4):393-9. PubMed ID: 11024374
    [Abstract] [Full Text] [Related]

  • 2. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection.
    Arslan A, Sezgin A, Gultekin B, Ozkan S, Akay T, Uguz E, Tasdelen A, Aslamaci S.
    Transplant Proc; 2005 Sep; 37(7):3219-22. PubMed ID: 16213352
    [Abstract] [Full Text] [Related]

  • 3. Coronary oxygen persufflation combined with HTK cardioplegia prolongs the preservation time in heart transplantation.
    Kuhn-Régnier F, Fischer JH, Jeschkeit S, Switkowski R, Bardakcioglu O, Sobottke R, de Vivie ER.
    Eur J Cardiothorac Surg; 2000 Jan; 17(1):71-6. PubMed ID: 10735415
    [Abstract] [Full Text] [Related]

  • 4. Custodial-HTK Solution for Myocardial Protection in CABG Patients.
    Prathanee S, Kuptanond C, Intanoo W, Wongbhudha C, Karunasumaeta C.
    J Med Assoc Thai; 2015 Aug; 98 Suppl 7():S164-7. PubMed ID: 26742385
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery.
    Gaudino M, Pragliola C, Anselmi A, Pieroni M, De Paulis S, Leone A, De Caterina AR, Massetti M.
    Scand Cardiovasc J; 2013 Dec; 47(6):359-67. PubMed ID: 24053647
    [Abstract] [Full Text] [Related]

  • 6. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients.
    Careaga G, Salazar D, Téllez S, Sánchez O, Borrayo G, Argüero R.
    Arch Med Res; 2001 Dec; 32(4):296-9. PubMed ID: 11440787
    [Abstract] [Full Text] [Related]

  • 7. Cardiac Troponin T to evaluate myocardial protection via intermittent cold blood or continuous warm blood cardioplegia in coronary artery bypass grafting.
    Astorri E, Fiorina P, Grattagliano C, Medici D, Pinelli S, Albertini D, Pincolini S, Barboso G, Albertini R.
    J Cardiovasc Surg (Torino); 1998 Dec; 39(6):797-802. PubMed ID: 9972902
    [Abstract] [Full Text] [Related]

  • 8. Comparative Analysis of Myocardial Protection with HTK Solution and Hypothermic Hyperkalemic Blood Solution in the Correction of Acyanogenic Congenital Cardiopathies - A Randomized Study.
    Valente AS, Lustosa GP, Mota LAM, Lima A, Mesquita FA, Gondim A, Rodrigues FA, Pompeu RG, Branco KC.
    Braz J Cardiovasc Surg; 2019 Jun 01; 34(3):271-278. PubMed ID: 31310464
    [Abstract] [Full Text] [Related]

  • 9. The efficiency of heart protection with HTK or HTK-N depending on the type of ischemia.
    Schaefer M, Gebhard MM, Gross W.
    Bioelectrochemistry; 2019 Feb 01; 125():58-69. PubMed ID: 30265864
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of terminal warm blood cardioplegia in combination with Bretschneider-HTK solution for myocardial protection].
    Morishita A, Kitamura M, Ishitoya H, Hachida M, Endoh M, Koyanagi H.
    Kyobu Geka; 1999 Sep 01; 52(10):831-5. PubMed ID: 10478544
    [Abstract] [Full Text] [Related]

  • 11. Effect of cold blood cardioplegia enriched with potassium-magnesium aspartate during coronary artery bypass grafting.
    Ji B, Liu J, Liu M, Feng Z, Wang G, Lu F, Long C.
    J Cardiovasc Surg (Torino); 2006 Dec 01; 47(6):671-5. PubMed ID: 17043614
    [Abstract] [Full Text] [Related]

  • 12. Comparison of routine del Nido cardioplegia vs two types of modified del Nido cardioplegias for myocardial protection among patients undergoing coronary artery bypass grafting (CABG) surgeries: A randomized double-blind clinical trial.
    Ali B, Butt SP, Nour MG, Khosravi MB, Asmarian N, Shoul AR, Kumar A, Darr U, Bhatnagar G.
    J Extra Corpor Technol; 2024 Sep 01; 56(3):84-93. PubMed ID: 39303129
    [Abstract] [Full Text] [Related]

  • 13. Myocardial protection using HTK solution in minimally invasive mitral valve surgery.
    Savini C, Camurri N, Castelli A, Dell'Amore A, Pacini D, Suarez SM, Grillone G, Di Bartolomeo R.
    Heart Surg Forum; 2005 Sep 01; 8(1):E25-7. PubMed ID: 15769709
    [Abstract] [Full Text] [Related]

  • 14. Del Nido cardioplegia versus blood cardioplegia in adult aortic root surgery.
    Lenoir M, Bouhout I, Jelassi A, Cartier R, Poirier N, El-Hamamsy I, Demers P.
    J Thorac Cardiovasc Surg; 2021 Aug 01; 162(2):514-522.e2. PubMed ID: 32111432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of cardioplegic solution on incidence of delirium after CABG surgery: Use of Calafiore blood cardioplegia versus HTK - Bretschneider - solution in a single-center retrospective analysis from 2017 to 2021.
    Irqsusi M, Loos D, Dielmann K, Ramzan R, Wulf H, Ghazy T, Vogt S, Rastan AJ.
    J Card Surg; 2022 Dec 01; 37(12):4670-4678. PubMed ID: 36321752
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of Bretschneider HTK cardioplegia solution and blood cardioplegia in terms of postoperative results in patients who underwent isolated supracoronary ascending aortic replacement.
    Tunca NU, Yesilkaya NK, Karaagac E, Durmaz H, Besir Y, Gokalp O, Iner H, Yılık L, Gurbuz A.
    Perfusion; 2024 Sep 01; 39(6):1205-1212. PubMed ID: 37290096
    [Abstract] [Full Text] [Related]

  • 19. Single-dose cardioplegia protects myocardium as well as traditional repetitive dosing: A noninferiority randomized study.
    Vivacqua A, Robinson J, Abbas AE, Altshuler JM, Shannon FL, Podolsky RH, Sakwa MP.
    J Thorac Cardiovasc Surg; 2020 May 01; 159(5):1857-1863.e1. PubMed ID: 31204129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.